Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07736937RecruitingPhase 1/Phase 2
Study of TUB-040 with Standard Drugs for Ovarian Cancer
This study tests a new medicine called TUB-040, given together with standard ovarian cancer drugs like carboplatin and bevacizumab. It is for women with ovarian cancer that has returned after responding to platinum-based chemotherapy and is growing again. The goal is to see if this combination can help control the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT07734610RecruitingPhase 1
Testing Nemtabrutinib in People with Severe Kidney Disease
This trial tests a new medicine (nemtabrutinib) in people with severe kidney disease to see how the body handles it. The study helps doctors decide safe doses for people with kidney problems.
Miami Lakes, FloridaAges 18–80 - NCT07737496RecruitingPhase 1
Study of HW243040 in healthy volunteers
This trial tests a new drug called HW243040 in healthy adults to see how safe it is. It helps researchers understand how the drug works in the body before testing it in patients with a condition.
Changsha, HunanAges 18–55 - NCT07739758RecruitingPhase 3
Study of two drugs for newly diagnosed extensive-stage small cell lung cancer
This trial tests a new combination of two drugs (YL201 and serplulimab) for people with extensive-stage small cell lung cancer who have not yet received treatment. The goal is to see if the combination helps shrink or control the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT07735533RecruitingPhase 1/Phase 2
UB-VV400 with rapamycin for large B-cell lymphoma
This trial tests an experimental treatment called UB-VV400 given with another drug, rapamycin, for people with large B-cell lymphoma that has not responded to standard therapy. The treatment targets a protein called CD22 on lymphoma cells and may help your immune system fight the cancer.
Nashville, TennesseeAges 18 years+ - NCT07735377RecruitingPhase 1
Study of SHR-6914 for Prostate Cancer
This study tests a new drug called SHR-6914 in men with prostate cancer that has spread. The goal is to see if it is safe and helps shrink or control the cancer, and to learn how the body processes it.
Guangzhou, GuangdongAges 18–80 - NCT07738991RecruitingPhase 1
Study of NKF-PEG compared to Neulasta in healthy men
This study tests a new medicine called NKF-PEG, which is similar to Neulasta (a drug that helps boost white blood cells after chemotherapy). It is being tested in healthy men to see how the body processes it and to check for side effects.
ZhengzhouAges 18–55 - NCT07733674RecruitingPhase 1
Testing a new imaging agent for brain and pancreatic tumors
This early-phase study tests a new imaging agent that may help see certain solid tumors (like brain cancer or pancreatic cancer) more clearly. You will receive a single injection of a radioactive tracer, then have several scans over a few days to see where the tracer goes and how long it stays.
Houston, TexasAges 18 years+ - NCT07736638RecruitingPhase 1
Testing safety and tolerability of ABBV-859 in healthy adults
This trial studies a new drug called ABBV-859 in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Anaheim, CaliforniaAges 18–65 - NCT07735104RecruitingPhase 1/Phase 2
Study of a new drug for cancer-related weight loss
This study tests a new medicine (QLS2319) to see if it’s safe and can help people with cancer-related weight loss and muscle loss (cachexia). It’s for people whose daily activities aren’t severely limited by their cancer.
Hefei, AnhuiAges 18–55 - NCT07734311RecruitingPhase 3
Testing a weight-loss injection for knee arthritis pain
This study tests whether an experimental weight-loss injection can reduce knee pain in people who are obese and have knee osteoarthritis. It may help if you have been unable to lose weight through diet and exercise and have moderate knee pain.
Wuhan, HubeiAges 18–75 - NCT05594095RecruitingPhase 2
Study for advanced ER+ HER2− breast cancer after CDK4/6 therapy
This Phase 2 trial tests an investigational “SNF platform” treatment for advanced ER+ (estrogen-receptor positive) and HER2− breast cancer in people who already tried CDK4/6 inhibitor therapy. It may help shrink tumors and improve outcomes for cancers that have come back or spread.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06318442Recruiting
Preventing steroid-induced diabetes with a GLP-1 drug
This study tests whether a GLP-1 medication (a type of drug that helps control blood sugar) can prevent diabetes caused by steroid treatments. It is for people who have prediabetes or mild diabetes and are about to receive a short course of steroids.
LondonAges 18 years+ - NCT05960370Recruiting
Testing a tighter embryo placement technique in natural frozen transfers
This study looks at whether “endometrial compaction” (a technique used during frozen embryo transfer) improves pregnancy and baby outcomes. It focuses on people having a frozen transfer using embryos that test normal on genetic screening.
MadridAges 18–50 - NCT05954741Recruiting
Rehab program to improve thinking in recent vascular memory problems
This trial tests a structured, multi-part rehabilitation program to help people with early dementia symptoms from vascular or mixed causes. If you qualify, you may be offered the rehab program and compared with another approach to see if thinking and daily function improve.
Montescano, PaviaAges 65–80 - NCT05974995Recruiting
Robotic or standard surgery for early uterine cancer in obesity
This trial compares robotic-assisted surgery versus standard laparoscopic surgery for people with early-stage uterine (endometrial) cancer and a BMI of 30 or higher. The goal is to see which approach is safer and works better for this group.
RomeAges 18–75 - NCT06625996Recruiting
Carbs before surgery for faster recovery
This study looks at whether drinking carbohydrate-rich liquids before surgery helps you recover faster. It is for people with heart conditions, but not for those who need insulin for diabetes.
AsyutAges 18 years+ - NCT06626178Recruiting
AI for preventing smoking-related diseases
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
MilanAges 18 years+ - NCT06628336Recruiting
Study of HARMONY Evolution hip replacement implants
This study looks at how well HARMONY Evolution implants and tools work for people getting a total hip replacement. It will help doctors understand if the implants are safe and effective over time.
BesançonAges 18–99 - NCT07729943Recruiting
Ginseng & Cordyceps for Better Exercise Performance
This trial tests whether a combination of ginseng and cordyceps (a type of mushroom) can help improve how well your body uses oxygen during exercise. It's for healthy, active adults aged 40 to 65 who want to see if these natural ingredients can boost stamina and recovery.
Canfield, OhioAges 40–65 - NCT07723963RecruitingPhase 2/Phase 3
Study of JZP926 for juvenile myoclonic epilepsy
This study tests an investigational drug called JZP926 (a type of cannabinoid) to see if it can reduce the number of days with myoclonic seizures in people with juvenile myoclonic epilepsy. If you have this condition and are at least 10 years old, you might be able to join.
Phoenix, ArizonaAges 10 years+ - NCT07729956RecruitingPhase 3
Study of BL-B01D1 plus immunotherapy for advanced triple-negative breast cancer
This trial tests a new drug called BL-B01D1 combined with an immunotherapy (PD-1 antibody) against a standard chemo/immu-notherapy combination. It is for people with previously untreated, advanced triple-negative breast cancer whose tumors have a protein called PD-L1.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07729852Enrolling by invitationPhase 2
Continuing access to ATH434 after the earlier study
This trial lets people who finished the earlier ATH434-201 study keep getting ATH434 (an experimental drug) on an open-label basis, meaning everyone knows they get the drug. If you were in that study and want to continue, this may help you keep receiving the treatment.
Toulouse, Midi-PyreneesAges Any age - NCT07732023RecruitingPhase 1
Study of a new asthma medication compared to placebo
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Chengdu, SichuanAges 18–70
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.